cephalosporin c has been researched along with tulathromycin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hart, FJ; Kilgore, WR; Nutsch, RG; Rooney, KA; Skogerboe, TL; Weigel, DJ | 1 |
| Hart, FJ; Kilgore, RW; Lechtenberg, KF; Meinert, TR; Nutsch, RG; Sunderland, SJ | 1 |
| Bryson, WL; Engelken, T; Holland, B; Johnson, JC; Krehbiel, C; Robb, EJ; Romano, C; Step, DL; Tucker, CM | 1 |
| Behan, S; Bryson, WL; Cortese, VS; Galvin, JE; Lucas, MJ; Penka, DR; Ramsey, D | 1 |
| Brumbaugh, GW; Sweeney, MT; Watts, JL | 1 |
| Berg, J; Booker, CW; Borciaga-Robles, LO; Fenton, RK; Hannon, SJ; Jim, GK; Perrett, T; Pollock, CM; Schunicht, OC; Vogstad, AR; Wildman, BK | 1 |
| Blondeau, BJ; Blondeau, JM; Blondeau, LD; Borsos, S; Hesje, CE | 1 |
| Foster, DM; Martin, LG; Papich, MG | 1 |
| Cameron-Veas, K; Fraile, L; Migura-Garcia, L; Moreno, MA | 1 |
| Dors, A; Kwit, K; Pejsak, Z; Pomorska-Mól, M; Wierzchosławski, K | 1 |
| Aldridge, B; Blair, B; Kancer, K; Lowe, J; Zeineldin, M | 2 |
| Blondeau, JM; Fitch, SD | 1 |
| Anderson, RC; Ives, SE; Lawhon, SD; Levent, G; Loneragan, GH; Norman, KN; Schlochtermeier, A; Scott, HM; Vinasco, J | 1 |
| Coetzee, JF; Cooper, VL; Engelken, TJ; Follett, L; Kleinhenz, MD; Krull, AC; Magstadt, DR; O'Connor, AM; Schuler, AM; Sidhu, PK | 1 |
6 trial(s) available for cephalosporin c and tulathromycin
| Article | Year |
|---|---|
Efficacy of tulathromycin injectable solution for the treatment of naturally occurring Swine respiratory disease.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disaccharides; Female; Gram-Negative Bacteria; Heterocyclic Compounds; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Mycoplasma hyopneumoniae; Pasteurellosis, Pneumonic; Severity of Illness Index; Swine; Swine Diseases; Treatment Outcome; United States | 2005 |
Efficacy of tulathromycin in the treatment of respiratory disease in pigs caused by Actinobacillus pleuropneumoniae.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Infective Agents; Cephalosporins; Disaccharides; Heterocyclic Compounds; Linear Models; Lung; Male; Swine; Swine Diseases; Treatment Outcome | 2006 |
Evaluation of three antimicrobial regimens used as metaphylaxis in stocker calves at high risk of developing bovine respiratory disease.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Cephalosporins; Disaccharides; Drug Therapy, Combination; Heterocyclic Compounds; Male; Risk Factors; Treatment Outcome | 2007 |
Efficacy of a florfenicol-flunixin meglumine combination product versus tulathromycin or ceftiofur crystalline free acid for the treatment of undifferentiated fever in feedlot calves.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Cephalosporins; Clonixin; Disaccharides; Drug Combinations; Fever; Heterocyclic Compounds; Housing, Animal; Thiamphenicol | 2009 |
Shedding of cephalosporin resistant Escherichia coli in pigs from conventional farms after early treatment with antimicrobials.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacterial Shedding; Cephalosporin Resistance; Cephalosporins; Disaccharides; Escherichia coli; Escherichia coli Infections; Feces; Heterocyclic Compounds; Risk Factors; Spain; Swine; Swine Diseases | 2016 |
Population Dynamics of
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Disaccharides; Feces; Heterocyclic Compounds; Lymph Nodes; Population Dynamics; Salmonella enterica; Skin | 2019 |
9 other study(ies) available for cephalosporin c and tulathromycin
| Article | Year |
|---|---|
Evaluation of two antimicrobial therapies in the treatment of Leptospira borgpetersenii serovar hardjo infection in experimentally infected cattle.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Disaccharides; Female; Heterocyclic Compounds; Leptospira; Leptospirosis; Random Allocation; Treatment Outcome | 2007 |
In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
Topics: Animals; Anti-Bacterial Agents; Bovine Respiratory Disease Complex; Cattle; Cephalosporins; Disaccharides; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Pasteurella multocida; Time Factors; Treatment Outcome | 2008 |
Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Thiamphenicol; Tylosin; United States | 2012 |
Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cattle; Cephalosporins; Cross-Over Studies; Disaccharides; Enrofloxacin; Epithelial Cells; Extracellular Fluid; Fluoroquinolones; Heterocyclic Compounds; Lung; Male; Mannheimia haemolytica; Microbial Sensitivity Tests; Respiratory Mucosa; Thiamphenicol; Veterinary Drugs | 2016 |
Effects of amoxicillin, ceftiofur, doxycycline, tiamulin and tulathromycin on pig humoral immune responses induced by erysipelas vaccination.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Vaccines; Cephalosporins; Disaccharides; Diterpenes; Doxycycline; Female; Heterocyclic Compounds; Immunity, Humoral; Male; Swine; Swine Erysipelas | 2016 |
Impact of parenteral antimicrobial administration on the structure and diversity of the fecal microbiota of growing pigs.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biodiversity; Cephalosporins; Disaccharides; DNA, Bacterial; Drug Combinations; Feces; Heterocyclic Compounds; Microbial Consortia; Microbiota; Molecular Sequence Data; Oxytetracycline; Penicillin G; Penicillin G Procaine; Phylogeny; RNA, Ribosomal, 16S; Swine; Time Factors | 2018 |
Microbial shifts in the swine nasal microbiota in response to parenteral antimicrobial administration.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Bacteroidetes; Cephalosporins; Clostridium; Disaccharides; Discriminant Analysis; DNA, Bacterial; Dose-Response Relationship, Drug; Firmicutes; Heterocyclic Compounds; Microbiota; Moraxella; Nose; Oxytetracycline; Penicillin G Procaine; Proteobacteria; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Streptococcus; Swine | 2018 |
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Topics: Actinobacillus pleuropneumoniae; Animal Husbandry; Animals; Anti-Bacterial Agents; Cephalosporins; Disaccharides; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Heterocyclic Compounds; Microbial Sensitivity Tests; Pasteurella multocida; Streptococcus suis; Swine; Swine Diseases; Thiamphenicol; Tylosin | 2019 |
Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bovine Respiratory Disease Complex; Cattle; Cephalosporins; Disaccharides; Drug Resistance, Microbial; Fluoroquinolones; Heterocyclic Compounds; Mannheimia haemolytica; Microbial Sensitivity Tests; Pasteurella multocida; Pasteurellaceae; Prospective Studies; Recurrence; Respiratory Tract Diseases; Serogroup; Tylosin | 2019 |